Oncology Data Advisor podkast

AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application

0:00
13:40
Do tyłu o 15 sekund
Do przodu o 15 sekund
Read the full article at: https://oncdata.com/ai-driven-pathological-subtyping-pancreatic-cancer-ashish-manne Artificial intelligence (AI) continues to generate excitement across oncology, but its real-world clinical impact remains inconsistent. In this episode of Exploring AI in Oncology, Dr. Ashish Manne, a Gastrointestinal Medical Oncologist at The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, shares his American Association for Cancer Research (AACR) presentation on AI-driven pathological subtyping in pancreatic cancer and highlights the critical shift that is moving AI from theoretical promise to practical application.

Więcej odcinków z kanału "Oncology Data Advisor"